Welcome to our dedicated page for International Flavors&Fragranc news (Ticker: IFF), a resource for investors and traders seeking the latest updates and insights on International Flavors&Fragranc stock.
International Flavors & Fragrances Inc. (NYSE: IFF) is a global leader in sensory experiences and specialty ingredients, serving industries from food technology to pharmaceutical solutions. This dedicated news hub provides investors and industry professionals with essential updates on IFF developments, including earnings reports, strategic partnerships, and scientific breakthroughs.
Key resources include: Quarterly financial results, innovation announcements in flavors/fragrances, bioscience advancements, and sustainability initiatives. Our curated collection ensures access to verified press releases and market analyses that impact IFF's position in the $120B+ specialty chemicals sector.
Bookmark this page for real-time updates on IFF's product launches, regulatory milestones, and leadership changes. Combine technical insights with strategic context to make informed decisions about this NYSE-listed innovator.
IFF (NYSE: IFF) has completed the divestiture of its nitrocellulose business, including the Walsrode Industrial Park in Germany, to Czechoslovak Group (CSG). The divested business, previously part of IFF's Pharma Solutions unit, specializes in manufacturing industrial nitrocellulose primarily used in coatings and printing inks. CEO Erik Fyrwald emphasized that this divestiture aligns with the company's deleveraging strategy and allows for increased focus on core business operations.
IFF (NYSE: IFF) has announced its quarterly dividend for Q2 2025. The Board of Directors has declared a regular quarterly cash dividend of $0.40 per share of common stock. The dividend will be payable on July 11, 2025 to shareholders of record as of June 20, 2025.
IFF is a global leader in flavors, fragrances, food ingredients, health and biosciences, focusing on delivering sustainable innovations for everyday products.
IFF has successfully completed the divestiture of its Pharma Solutions business unit to Roquette. CEO Erik Fyrwald announced that this strategic move has helped the company achieve its targeted net debt to credit-adjusted EBITDA ratio of below 3.0x.
The divestiture marks a significant milestone for IFF, enabling the company to focus on its core strategy and maximize shareholder value by capitalizing on growth opportunities within its key businesses. The company expressed gratitude to the Pharma Solutions team for their dedication to customer service.
IFF remains a global leader in flavors, fragrances, food ingredients, health and biosciences, delivering sustainable innovations for everyday products that enhance wellness and the human experience.
IFF Pharma Solutions will showcase its sustainable pharmaceutical innovations at Excipient World 2025, taking place May 13-14 at the Gaylord National Resort and Convention Center in Maryland. The company will present its portfolio at booth 205, featuring sustainable solutions, controlled-release formulations, and nitrosamine risk mitigation products.
Key highlights include:
- Presentation of METHOCEL™, ETHOCEL™, and POLYOX™ product lines
- Introduction of Low Nitrite METHOCEL™ and Avicel® PH LN for reducing nitrosamine risks
- Sustainability expert Dr. Anne Adden's presentation on "Sustainable by Design: The Future of Excipients" on May 13
The event will showcase IFF's 75+ years of industry expertise in polymer innovations. Dr. Adden, global strategic marketing director for sustainability and dietary supplements, emphasizes the company's commitment to creating sustainable healthcare solutions that address both current needs and future challenges.
IFF (NYSE: IFF) has announced a significant expansion of its pet portfolio, introducing advanced biotechnology solutions for companion animal care. The company has launched new products including Microsource™ CA for cat litter management and Betafin® Pet for pet hydration and gut health.
The expansion is supported by specialized R&D centers including the Pet Translational Research Lab (Wilmington, DE), Pet Enzymes Lab (Brabrand, Denmark), and Pet Applications Lab (New Century, KS). The new portfolio features enzyme-driven palatability solutions, sustainable ingredients, and functional health technologies.
Microsource™ CA reduces fecal ammonia odors by four times within 7 days, while Betafin® Pet offers natural betaine for both dogs and cats. The portfolio also includes enzymes, probiotics, plant protein, food protection solutions, natural colors, and proprietary flavor technology.
IFF (NYSE: IFF) Pharma Solutions has announced its participation at Vitafoods™ Europe 2025, showcasing its plant-based dietary supplement ingredients portfolio. The event will take place May 20-22 at the Fira Barcelona Gran Via, booth 4F25.
The company will present several innovative brands including SeaGel®, VERDIGEL™ SC, GRINDSTED® Pectin Premium, Ac-Di-Sol®, Avicel®, Accelerate®, and METHOCEL™. These products offer solutions ranging from vegan softgels and plant-based gummies to tablet binders and disintegrants.
The showcase highlights IFF's commitment to advancing the dietary supplement industry through high-performance, plant-based ingredients and reliable technologies for immediate and controlled release applications.
FAQ
What is the current stock price of International Flavors&Fragranc (IFF)?
What is the market cap of International Flavors&Fragranc (IFF)?
